Fosun Holds Its 4th “515 Fosun Family Day” as Scheduled

Due to a sudden outbreak of COVID-19 in March this year, people's normal life is at a standstill, and the hustle and bustle of the city is faltering. However, a close rapport between neighbors is being reestablished with the distribution of greens, a can of cola, or a few eggs. The epidemic hasn't stopped citizens' kindnesses towards ea

Fosun Foundation’s 40-day Anti-epidemic Efforts to Protect Shanghai Do More and Do Better for the City

(Shanghai, 12 May 2022) In face of the COVID-19 outbreak started in March in Shanghai, Fosun Foundation has successively launched three projects, “Community Support”, “Care for Elderly” and “Care for Children”, which are aimed at providing targeted assistance to communities, the elderly, women and children, etc.As of 10 May, Fosun

Fosun Diagnostics obtained CE mark for Its Self-developed Covid-19 Antigen CARD Kit

On 10 May 2022, the Covid-19 Antigen CARD Kit (the Kit) self-developed by Fosun Diagnostics, a subsidiary company of Fosun Pharma was awarded the CE certificate and it will be now made available across 27 EU countries as well as regions that recognize the CE marked.This Kit has significant advantages such as being accurate, fast and convenient which can be easily pe

Henlius and Eurofarma Entered into a License Agreement for Henlius' 3 Products in Latin America

Shanghai, China, May 11th, 2022 - Shanghai Henlius Biotech, Inc. (2696.HK) today announced it has entered into a license and collaboration agreement with Eurofarma Laboratórios SA ("Eurofarma"), a leading Brazilian pharmaceutical company with considerable experience in introducing and marketing innovative medical products throughout Latin America&

Fosun International 2021 ESG Report Highlights in a Glance